C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom

Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
12/2002
12/11/2002	EP1263724A1 Novel compounds
12/11/2002	EP1263722A1 Pharmaceutical compositions containing azetidine derivatives, novel azetidine derivatives and preparation thereof
12/11/2002	EP1263721A1 Pharmaceutical compositions containing 3-amino-azetidine derivatives, novel derivatives and preparation thereof
12/11/2002	EP1263720A1 Azetidine derivatives, preparation thereof and pharmaceutical compositions containing same
12/11/2002	EP1263504A2 Compounds with 5-ht1a activity useful for treating disorders of the outer retina
12/11/2002	EP1263503A2 Use of cyanoquinolines for treating or inhibiting colonic polyps
12/11/2002	EP1263434A1 Compounds with 5-ht 2 and 5-ht 1a agonist activity for treating glaucoma
12/11/2002	EP1263301A1 Method and system for assay and removal of harmful toxins during processing of tobacco products
12/11/2002	EP1095025B1 Benzimidazoles, production thereof and use thereof as medicaments
12/11/2002	EP1058678B1 Metal-catalyzed arylations and vinylations of hydrazines, hydrazones, hydroxylamines and oximes
12/11/2002	EP1023072B1 Analgesic compositions comprising a cholecystokinin and an opioid
12/11/2002	EP0984943B1 Azacyclooctane and heptane derivatives, their preparation and usein therapy
12/11/2002	EP0981521B1 Novel macrocyclic compounds as metalloprotease inhibitors
12/11/2002	EP0966436B1 Aryl sulfonamides and analogues thereof and their use in the treatment of neurodegenerative diseases
12/11/2002	EP0937064B1 Substituted oximes derivatives useful as neurokinin antagonists
12/11/2002	EP0925294B1 Substituted 2(2,6-dioxopiperidin-3-yl)phthalimides and -1-oxoisoindolines and method of reducing tnf-alpha levels
12/11/2002	EP0723447B1 Use of (2-imidazolin-2-ylamino) quinoxaline derivatives
12/11/2002	EP0721455B1 Tetrahydropyridine-(or 4-hydroxypiperidine)alkylazoles having an affinity for sigma and/or 5ht1a receptors
12/11/2002	EP0662958B1 1-(2-oxo-acetyl)-piperidine-2-carboxylic acid derivatives as multi-drug-resistent cancer cell sensitizers
12/11/2002	CN1384870A Method of bleaching stained fabrics
12/11/2002	CN1384869A Method of pretreating and bleaching stained fabrics
12/11/2002	CN1384837A Ligand and complex for catalytically bleaching substrate
12/11/2002	CN1384831A Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
12/11/2002	CN1384830A Novel spiroheterocyclic compoundsus reversible inhibitors of cysteine proteases
12/11/2002	CN1384829A Sodium-hydrogen exchanger type 1 inhibitor crystals
12/11/2002	CN1384825A Benzylidene thiazolidiones and analogues and their use in treatment of inflammation
12/11/2002	CN1384100A Benzo-1,3-dioxole and benzofuran substituted pentazane derivative
12/11/2002	CN1095837C Pyridazinone and application as fungicide
12/11/2002	CN1095835C Tricyclo-substituted isohydroxyloxime acid derivative
12/11/2002	CA2411165A1 Novel indole derivatives exhibiting chymase-inhibitory activities and process for preparation thereof
12/10/2002	US6492553 A method for preparing a n-((aliphatic or aromatic)carbonyl) )-2-aminoacetamide compound, and for preparing a cyclized compound therefrom, as well as novel resin bound intermediate compounds that are useful for preparing such compounds.
12/10/2002	US6492529 Bis pyrazole-1H-pyrazole intermediates and their synthesis
12/10/2002	US6492518 Tinuvin P-hindred amine light stabilizer and derivatives thereof
12/10/2002	US6492516 Pharmaceutically acceptable salts thereof which exhibit utility for the treatment of cytokine mediated diseases such as arthritis.
12/10/2002	US6492440 Block oligomers containing 1-hydrocarbyloxy-2,2,6,6-tetramethyl-4-piperidyl groups as stabilizers for organic materials
12/10/2002	US6492423 Hepatitis c and b viricides
12/10/2002	US6492411 Substituted pyrazolyl benzenesulfonamides for the treatment of inflammation
12/10/2002	US6492407 Pharmaceutical compositions containing triazolones and methods of treating neurodegenerative disease using triazolones
12/10/2002	US6492406 Pharmaceutically active compounds
12/10/2002	US6492401 Sodium hydrogen exchanger type 1 inhibitors; reducing perioperative myocardial tissue damage
12/10/2002	US6492400 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
12/10/2002	US6492397 N-arylheteroarylalkyl imidazol-2-one compounds for treatment of arteriosclerosis
12/10/2002	US6492393 Compounds useful as anti-inflammatory agents
12/10/2002	US6492392 2-piperidone compounds
12/10/2002	US6492390 Treating cyclooxygenase-2 mediated disorders.
12/10/2002	US6492387 Isoindolyl and isoquinolinyl aroyl pyrrole compounds
12/10/2002	US6492381 Tricyclic carbamate compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
12/10/2002	US6492376 Polyhydroxylated monocyclic N-heterocyclic derivatives as anti-coagulants
12/10/2002	US6492375 Administering a piperidine compound
12/10/2002	US6492373 6-fluoro-1,4-dihydro-7-[4-(2-hydroxyiminoethyl)-1-piperazinyl]-4-oxoquinoline-3-carboxylic acid derivatives, their preparation and pharmaceutical compositions
12/10/2002	US6492372 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4
12/10/2002	US6492367 Sulfamato hydroxamic acid metalloprotease inhibitor
12/10/2002	US6492366 Cyano-indole serotonin-reuptake inhibitor compound
12/10/2002	US6492365 Microsomal triglyceride transfer protein
12/10/2002	US6492360 Phthalazine derivatives phosphodiesterase 4 inhibitors
12/10/2002	CA2230445C Fibrinogen receptor antagonists and medicinal preparations containing the same as the active ingredient
12/10/2002	CA2208792C Substituted indazole derivatives
12/10/2002	CA2116773C Triazolylated tertiary amine compound or salt thereof
12/10/2002	CA2109934C Substituted indoles as anti-aids pharmaceuticals
12/05/2002	WO2002096903A2 Chemical derivatives and the use thereof as an anti-telomerase agent
12/05/2002	WO2002096902A1 Carbazole derivatives and their use for the preparation of pharmaceutical compositions for the treatment of npy related diseases
12/05/2002	WO2002096888A1 Cdk inhibiting pyrimidines, production thereof and their use as medicaments
12/05/2002	WO2002096886A1 Pyrimidine derivatives
12/05/2002	WO2002096885A1 Pyrimidine derivatives useful as selective cox-2 inhibitors
12/05/2002	WO2002096879A1 Aminoquinoline and aminopyridine derivatives and their use as adenosine a3 ligands
12/05/2002	WO2002096876A1 Carbamate and oxamide compounds as inhibitors of cytokine production
12/05/2002	WO2002096875A1 4-hydroxpiperidine derivative with analgetic activity
12/05/2002	WO2002096873A1 Isoindole and isoquinoline derivatives as inhibitors of factor xa
12/05/2002	WO2002096867A2 Inhibitors of protein kinase for the treatment of disease
12/05/2002	WO2002096864A1 Carboxamide-substituted phenylurea derivatives and method for production thereof as medicaments
12/05/2002	WO2002096516A1 Use of compositions comprising cyclooxygenase-2 selective inhibitors in combination with radiation for inhibition or prevention of cardiovascular disease
12/05/2002	WO2002096426A1 Hydantion derivatives as inhibitors of matrix metalloproteinases
12/05/2002	WO2002096421A1 5-substituted-2-arylpyridines as crf1 modulators
12/05/2002	WO2002096420A2 Method for treating nerve injury caused by surgery
12/05/2002	WO2002096361A2 5-aralkylsulfonyl-3- (pyrrol-2-ylmethylidene)-2-indolinone derivatives as kinase inhibitors
12/05/2002	WO2002078693A3 N-(2-arylethyl)benzylamines as antagonists of the 5-ht6 receptor
12/05/2002	WO2001093840A2 Ligands of integrin receptors
12/05/2002	US20020183523 Cis-substituted aminocyclopropane derivative
12/05/2002	US20020183375 For therapy of depression, anxiety, affective disorders, feeding disorders, post-traumatic stress disorder, headache, drug addiction, inflammatory disorders, drug or alcohol withdrawal symptoms
12/05/2002	US20020183364 Methods of modulating protein tyrosine kinase function with substituted indolinone compounds
12/05/2002	US20020183363 Reacting benzimidazole compound with m-chloroperoxybenzoic acid in a solvent selected from the group consisting of acetone and acetone/water mixture; raising the pH of the reaction mixture; crystals are separated
12/05/2002	US20020183360 Substituted 2-(2,6-dioxopiperidin-3-YL)-phthalimides and -1-oxoisoindolines and method of reducing TNFalpha levels
12/05/2002	US20020183358 Administering compounds, e.g., 8-methoxy-2-trifluoromethylquinoline-5-carboxylic acid (3,5-dichloro-1-oxypyridin-4-yl)amide for therapy of disease state that is capable of being modulated by inhibition of phosphodiesterase
12/05/2002	US20020183325 Phthalazinone derivatives
12/05/2002	US20020183324 Monocyclic or bicyclic carbocycles and heterocycles as factor Xa inhibitors
12/05/2002	US20020183323 For therpay of inflammatory bowel disease, cerebral ischemia and arthritis, adult respiratory distress syndrome (ARDS) and myocarditis, as adjuvants to short term immunosuppression in transplant therapy
12/05/2002	US20020183316 Amidoalkyl-piperidine and amidoalkyl-piperazine derivatives useful for the treatment of nervous system disorders
12/05/2002	US20020183313 Cholecystokinin-A and B (CCK-A/B) antagonists and useful in therapy and prophylaxis of disorders of appetite regulatory systems (e.g., anorexia) disorders associated with intestinal smooth muscle hyperactivity (e.g., irritable bowel syndrome)
12/05/2002	US20020183241 Methods for treating vertigo and motion sickness using descarboethoxyloratadine
12/05/2002	US20020182147 Vitronectin receptor antagonist pharmaceuticals
12/05/2002	DE10127041A1 New glycine N-(1-biphenyl-4-yl-2-substituted-ethyl)-amides, are integrin receptor inhibitors useful for treating e.g. angiogenic, cardiovascular, inflammatory and osteolytic or tumor diseases
12/05/2002	DE10125567A1 New N-aroyl-N'-(carbamoyl-phenyl)-urea derivatives, are glycogen phosphorylase a inhibiting hypoglycemic agents, especially useful for treating type II diabetes
12/05/2002	DE10125131A1 Verfahren zur Spaltung des Methyl A process for the cleavage of the methyl 4-(2-chlor-4-fluorphenyl)-2-(3,5-difluor-2-pyridinyl)-6-methyl-1,4-dihydro-5-pyrmidincarboxylat-Racemats
12/05/2002	CA2449118A1 Cdk inhibiting pyrimidines, production thereof and their use as medicaments
12/05/2002	CA2449019A1 Method for treating nerve injury caused by surgery
12/05/2002	CA2448626A1 Carbamate and oxamide compounds as inhibitors of cytokine production
12/05/2002	CA2448509A1 4-hydroxypiperidine derivatives having analgesic activity
12/05/2002	CA2448198A1 5-substituted-2-arylpyridines as crf1 modulators
12/05/2002	CA2448192A1 Pyrimidine derivatives useful as selective cox-2 inhibitors
12/05/2002	CA2448023A1 Carboxamide-substituted phenylurea derivatives and method for production thereof as medicaments

1 ... 726 727 728 729 730 731 732 733 734 735 736 737 738 739 740 741 742 743 744 745 746 ... 1080